# Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Article · Paul M. Ridker, James H. Revkin, Pierre Amarenco, Robert Brunell, Madelyn Curto, Fernando Civeira, Marcus D Flather, Robert J. Glynn, Jean C. Grégoire, J. Wouter Jukema, Yuri Karpov, John J.P. Kastelein, Wolfgang Köenig, Alberto J. Lorenzatti, Pravin Manga, URSZULA S. MASIUKIEWICZ, Michael J. Miller, Arend Mosterd, Ján Murín, José Carlos Nicolau, Steven E. Nissen, Piotr P. Ponikowski, Raul Dias Santos, Pamela F. Schwartz, Handrean Soran and 6 more

- Archive id: doi:10.1056/nejmoa1701488
- Published: 2017-03-17
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa1701488
- PMID: 28304242
- Citations: 624
- Source URL: https://doi.org/10.1056/nejmoa1701488
- PDF: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488?articleTools=true
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.